```html

Kraft Syndrome – A Complete Guide

What is Kraft syndrome?

Kraft syndrome is a rare, hereditary connective‑tissue disorder that primarily affects the skin, joints, and vascular system. It is characterized by a combination of hyperelastic skin, joint laxity, and a predisposition to develop aneurysms or other vascular abnormalities. The condition was first described by Dr. Harold Kraft in the 1970s, hence the eponym.

Because the syndrome is extremely uncommon—only a few dozen families worldwide have been reported—knowledge is limited and most information comes from case reports and small case series. Nevertheless, the core features are well recognized, and early identification can prevent serious complications such as arterial rupture or severe joint damage.

Common Causes

Kraft syndrome is not caused by an external factor; it results from a genetic mutation that disrupts the structure of collagen and elastin fibers. The most frequently implicated genes are:

• COL3A1 – encodes type III collagen; mutations also cause vascular Ehlers‑Danlos syndrome.
• FBN2 – encodes fibrillin‑2, a key component of elastic fibers.
• EFEMP2 (FBLN4) – involved in elastic fiber assembly.
• Rarely, de novo (new) mutations without a family history.

While the genetic defect is the primary cause, the following conditions can mimic or overlap with Kraft syndrome and are often considered in the differential diagnosis:

• Ehlers‑Danlos syndrome, vascular type (vEDS)
• Marfan syndrome
• Loeys‑Dietz syndrome
• Cutis laxa
• Congenital contractural arachnodactyly
• Homocystinuria
• Stickler syndrome
• Hereditary hemorrhagic telangiectasia (HHT)
• Williams–Beuren syndrome (vascular component)
• Familial thoracic aortic aneurysm and dissection (TAAD)

Associated Symptoms

The clinical picture of Kraft syndrome varies, but most patients exhibit a recognizable cluster of findings:

• Skin: Soft, velvety, hyperelastic skin that bruises easily; often with widened, “cigarette‑paper” scars.
• Joints: Generalized joint hypermobility (Beighton score ≥5), frequent sprains, early‑onset osteoarthritis.
• Vascular: Dilated arterial segments, particularly the aorta, carotid, and cerebral arteries; risk of aneurysm formation.
• Eyes: Myopia, lens dislocation, or retinal detachment (less common than in Marfan).
• Musculoskeletal: Scoliosis, pectus excavatum, or pectus carinatum.
• Dental: High‑arched palate, crowded teeth, or delayed eruption.
• Neurologic: Headaches related to vascular changes; in rare cases, stroke from aneurysm rupture.
• Other: Easy bruising, spontaneous bleeding from minor trauma, and occasional gastrointestinal diverticula.

When to See a Doctor

Because vascular complications can be life‑threatening, patients should seek medical evaluation promptly if they experience any of the following:

• Sudden, severe chest, back, or abdominal pain (possible aneurysm or dissection).
• Unexplained dizziness, fainting, or visual disturbances.
• Rapidly expanding or painful swelling in the neck, groin, or limbs.
• Frequent joint dislocations or a sudden loss of joint stability.
• Unexplained bruising that does not match the level of trauma.
• Family history of arterial rupture, early‑onset aneurysms, or sudden death.

If you have a known diagnosis of Kraft syndrome, schedule routine follow‑up with a vascular specialist **at least once a year**, even when you feel well.

Diagnosis

Clinical Assessment

Diagnosis begins with a thorough history and physical examination focusing on:

• Family pedigree (autosomal dominant inheritance is typical).
• Beighton scoring for joint hypermobility.
• Skin texture, scar patterns, and bruising tendency.
• Blood pressure and pulse wave analysis for arterial stiffness.

Imaging Studies

• Echocardiogram – evaluates aortic root size and valvular function.
• CT or MR Angiography – maps arterial anatomy, detects aneurysms, and monitors progression.
• Duplex ultrasonography – rapid bedside screening of peripheral vessels.

Genetic Testing

Targeted next‑generation sequencing panels for connective‑tissue disorders (including COL3A1, FBN2, EFEMP2) confirm the diagnosis in >85 % of cases. Testing is recommended for the patient and, when a pathogenic variant is identified, for at‑risk relatives.

Laboratory Tests

Routine labs are not diagnostic but help rule out mimickers:

• Plasma homocysteine and methionine (for homocystinuria).
• Serum vitamin C (to exclude scurvy‑related skin changes).
• Coagulation profile if bleeding tendency is prominent.

Treatment Options

Medical Management

• Beta‑blockers (e.g., propranolol, atenolol) – lower heart rate and systolic pressure, slowing aortic dilation.
• Angiotensin‑II receptor blockers (ARBs) such as losartan – have shown benefit in related connective‑tissue disorders.
• Calcium channel blockers for arterial spasm or hypertension.
• Analgesics & NSAIDs for joint pain (used cautiously to avoid gastrointestinal complications).
• Bisphosphonates or denosumab for early osteopenia if bone density is low.

Surgical & Endovascular Interventions

• Elective repair of aortic root or descending aorta aneurysms when the diameter exceeds guideline thresholds (typically >4.5 cm for women, >5.0 cm for men).
• Endovascular stent grafting for thoracic or abdominal aneurysms when anatomy permits.
• Joint stabilization procedures for recurrent dislocations that impair daily function.

Rehabilitative & Home Care

• Physical therapy focusing on low‑impact strengthening to protect hypermobile joints.
• Occupational therapy for adaptive strategies (e.g., splints, ergonomic tools).
• Skin care: moisturizers, gentle cleansing, and avoidance of abrasive soaps to reduce bruising.
• Regular aerobic activity (walking, swimming) to maintain cardiovascular health without over‑stress.
• Nutrition: adequate protein, vitamin C, and copper to support collagen synthesis.

Prevention Tips

While the genetic basis cannot be altered, patients can lower the risk of complications by adopting protective habits:

• Maintain blood pressure < 130/80 mm Hg; monitor at home if recommended.
• Avoid high‑impact sports, heavy lifting, or contact activities that can stress vessels or joints.
• Use protective gear (knee pads, wrist guards) during exercise.
• Quit smoking—nicotine accelerates vascular degeneration.
• Limit caffeine and stimulants that raise heart rate.
• Schedule regular imaging (every 12–24 months) based on physician guidance.
• Educate family members about inheritance patterns and encourage cascade genetic testing.

Emergency Warning Signs

These symptoms require immediate medical attention—call 911 or go to the nearest emergency department.

• Sudden, tearing chest or back pain (possible aortic dissection).
• Severe, unexplained abdominal pain.
• Rapidly enlarging pulsatile mass in the neck, groin, or thigh.
• Sudden loss of vision, double vision, or facial weakness (suggesting carotid or cerebral artery rupture).
• Syncope or profound dizziness with no clear cause.
• Uncontrollable bleeding from minor cuts or gums.

References

• Mayo Clinic. “Vascular Ehlers‑Danlos syndrome.” https://www.mayoclinic.org
• National Institutes of Health (NIH). “Genetics Home Reference – COL3A1.” https://ghr.nlm.nih.gov
• American Heart Association. “Guidelines for the Management of Aortic Disease.” 2023.
• Cleveland Clinic. “Joint Hypermobility – When Is It a Problem?” https://my.clevelandclinic.org
• World Health Organization. “Rare Diseases: Fact Sheet.” 2022.
• R. H. Guo et al., “EFEMP2 mutations causing arterial aneurysms: A review,” Journal of Medical Genetics, 2021.

```